MX2022000848A - Composiciones amortiguadoras para reducir la agregacion. - Google Patents

Composiciones amortiguadoras para reducir la agregacion.

Info

Publication number
MX2022000848A
MX2022000848A MX2022000848A MX2022000848A MX2022000848A MX 2022000848 A MX2022000848 A MX 2022000848A MX 2022000848 A MX2022000848 A MX 2022000848A MX 2022000848 A MX2022000848 A MX 2022000848A MX 2022000848 A MX2022000848 A MX 2022000848A
Authority
MX
Mexico
Prior art keywords
kits
compositions
methods
buffer compositions
reducing aggregation
Prior art date
Application number
MX2022000848A
Other languages
English (en)
Inventor
Jean- Sebastien COTE
Marie- Christine Fortin
Vincent Blanchette
Marie- Helene TREMBLAY
Sebastien Morasse
Sophie Guay
Sebastien Simard
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of MX2022000848A publication Critical patent/MX2022000848A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La descripción incluye composiciones, equipos y métodos para la detección e identificación basadas en ácidos nucleicos de trastornos vaginales, por ejemplo, candidiasis vulvovaginal, tricomoniasis y/o vaginosis bacteriana. Las composiciones, equipos y métodos pueden utilizarse para obtener un desempeño robusto de la prueba de diagnóstico contra las sustancias interferentes, por ejemplo, geles presentes en las muestras clínicas de los frotis vaginales.
MX2022000848A 2019-07-26 2020-07-22 Composiciones amortiguadoras para reducir la agregacion. MX2022000848A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962879310P 2019-07-26 2019-07-26
PCT/US2020/043093 WO2021021522A1 (en) 2019-07-26 2020-07-22 Buffer compositions for reducing aggregation

Publications (1)

Publication Number Publication Date
MX2022000848A true MX2022000848A (es) 2022-03-17

Family

ID=74230802

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022000848A MX2022000848A (es) 2019-07-26 2020-07-22 Composiciones amortiguadoras para reducir la agregacion.

Country Status (9)

Country Link
US (1) US20220145373A1 (es)
EP (1) EP4004203A4 (es)
JP (1) JP2022543209A (es)
KR (1) KR20220037475A (es)
CN (1) CN114341352A (es)
AU (1) AU2020323881A1 (es)
CA (1) CA3148761A1 (es)
MX (1) MX2022000848A (es)
WO (1) WO2021021522A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150708A1 (en) * 2022-02-05 2023-08-10 Becton, Dickinson And Company Method for separating genomic dna for amplification of short nucleic acid targets
WO2023225362A1 (en) * 2022-05-19 2023-11-23 Cepheid Mvp cartridge and methods of use and manufacture

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477017A1 (en) * 2002-02-19 2003-08-28 Choicepoint Asset Company Selective extraction of dna from groups of cells
WO2004024919A1 (en) * 2002-09-13 2004-03-25 Replicor, Inc. Non-sequence complementary antiviral oligonucleotides
JP5106416B2 (ja) * 2006-01-06 2012-12-26 アジレント・テクノロジーズ・インク 濃縮（ｐａｃｋｅｄ）ＤＮＡポリメラーゼを含む核酸複製のための反応緩衝液組成物
KR20090098957A (ko) * 2006-09-12 2009-09-18 시에라 몰레큘러 코포레이션 카오트로프의 완충용액을 사용하는 핵산을 대상으로 하는 분자분석 간섭의 제거
US20110262989A1 (en) * 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US8741563B2 (en) * 2011-11-23 2014-06-03 Medical Diagnostic Laboratories, Llc Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorphisms
US9663770B2 (en) * 2014-01-22 2017-05-30 Life Technologies Corporation Reverse transcriptases for use in high temperature nucleic acid synthesis
EP3135769A1 (en) * 2015-08-26 2017-03-01 Qiagen GmbH Kits and methods for extracting rna
RU2651937C1 (ru) * 2017-05-04 2018-04-24 Татьяна Георгиевна Фалеева Композиция для сбора и хранения днк или днк-содержащих биологических следов (варианты) и её применение

Also Published As

Publication number Publication date
CA3148761A1 (en) 2021-02-04
WO2021021522A1 (en) 2021-02-04
EP4004203A1 (en) 2022-06-01
US20220145373A1 (en) 2022-05-12
KR20220037475A (ko) 2022-03-24
EP4004203A4 (en) 2023-07-26
AU2020323881A1 (en) 2022-03-03
CN114341352A (zh) 2022-04-12
JP2022543209A (ja) 2022-10-11

Similar Documents

Publication Publication Date Title
EP4257705A3 (en) Biomarkers of traumatic brain injury
Burillo et al. Use of rapid diagnostic techniques in ICU patients with infections
MX2022000848A (es) Composiciones amortiguadoras para reducir la agregacion.
WO2017172644A3 (en) Bacteria identification and antibiotic susceptibility profiling device
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
WO2015157704A3 (en) Methods and compositions for detecting misfolded proteins
EP3816303A3 (en) Breast cancer detection kit or device, and method for detecting breast cancer
WO2017027611A3 (en) Biomarkers of methylglyoxal and related methods thereof
MX342735B (es) Diagnostico acompañante para terapia con agente anti-hialuronano y metodos de uso del mismo.
WO2020055954A3 (en) Methods for detecting liver diseases
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
PH12020551371A1 (en) Assays to detect neurodegeneration
AU2018286823A1 (en) Compressible extraction instrument for pretreating a sample
MX2016009516A (es) Medicion rapida de la tasa de sedimentacion de los componentes sanguineos formados a partir de pequeños volumenes de muestra.
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
GB201014837D0 (en) Biomarker signatures and uses thereof
WO2016085997A3 (en) Determination of fertility potential from the oxidation-reduction potential of a biological sample
EP3954997A4 (en) HEXOKINASE 2 FOR DETECTION AND TESTING KIT FOR SPARE NEOPLASTIC CELLS IN A BODY FLUID SAMPLE
Gual et al. First case report of Toxoplasma gondii-induced abortions and stillbirths in sheep in Argentina
WO2018187385A8 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING PANCREATIC CANCER
MX2019004207A (es) Un metodo de diagnostico complementario para el uso en el tratamiento del sindrome de intestino irritable con dietas de intervencion o trasplante de microbiota fecal.
EP4068306A4 (en) METHOD AND APPARATUS FOR CALCULATING THE PROBABILITY OF BEING INFECTED WITH A DISEASE OR HAVING A DISEASE, AND METHOD AND APPARATUS FOR ISSUEING PERSONS TO BE TESTED FOR A DISEASE
WO2018065108A3 (en) Analysis system for testing a sample
Torres et al. Preliminary psychometric characteristics of the Portuguese version of Patient Health Questionnaire 9 (PHQ-9) in a sample of Portuguese breast cancer women
WO2015200833A3 (en) COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2)